Complicated Urinary Tract Infections in Children: Vabomere Study

We are studying the safety and effectiveness of Vabomere for children aged 3 months to under 12 years with complicated urinary tract infections. This research aims to improve treatment options for these young patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Meropenem
Meropenem is an antibiotic substance used to treat serious bacterial infections, including severe or hospital-acquired infections.
Vaborbactam
Vaborbactam is a substance that blocks bacterial enzymes that destroy some antibiotics, helping those antibiotics treat resistant infections.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Meropenem-Vaborbactam

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Pediatric Clinical Research Unit
Heverlee, Belgium
Centre Hospitalier Regional De La Citadelle
Department of Pediatric Nephrology
Liège, Belgium
Multiprofile Hospital For Active Treatment Dr. Tota Venkova AD
Department of Pediatric Diseases
Gabrovo, Bulgaria

Sponsor: Rempex Pharmaceuticals Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.